Christoph Uleer
4PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 25, 2025
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.Peter A Fasching, Sabine Schmatloch, Jan Hauke
|Jan 09, 2025
RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial.Guillermo Villacampa, Alba Llop-Guevara, Natalie Filmann
|Jul 07, 2022
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.Oleg Gluz, Ulrike Nitz, Cornelia Kolberg-Liedtke
|Apr 11, 2022
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer.Ulrike A Nitz, Oleg Gluz, Sherko Kümmel
Pageof 1
Frequent Collaborators
2 joint publications
Oleg Gluz
2 joint publications
Carsten Denkert
2 joint publications
Peter Klare
2 joint publications
Bahriye Aktas
2 joint publications
Valentina Nekljudova
2 joint publications
Peter A Fasching
2 joint publications
Gabriele Doering
2 joint publications
Andrea Stefek
2 joint publications
Nadia Harbeck
2 joint publications
Monika Gräser
